Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Leandro

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|October 8, 2014
Abnormal antibodies: what do you do?Maria Mouyis, Maria Leandro
British Journal of Haematology|May 27, 2009
Rituximab in non-haematological disorders of adults and its mode of actionVickie McDonald, Maria Leandro
Lupus|January 18, 2021
Rituximab - The first twenty yearsMaria Leandro, David A Isenberg
Arthritis Research & Therapy|June 8, 2004
B cell depletion in autoimmune diseaseClaire Gorman, Maria Leandro, David Isenberg
Dermatologic Therapy|August 7, 2013
Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumabThivi Maruthappu, Maria Leandro, Susie D Morris
Biologicals : Journal of the International Association of Biological Standardization|December 8, 2020
Anti-CD20 monoclonal antibodies in Systemic Lupus ErythematosusKavina Shah, Mark Cragg, Maria Leandro, et al.
BMC Rheumatology|September 6, 2019
Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysisAshleigh Hennessey, Joanna Lukawska, Geraldine Cambridge, et al.
Drug Discovery Today|June 26, 2016
Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?Venkat Reddy, Lekh N Dahal, Mark S Cragg, et al.
Rheumatology (Oxford, England)|March 26, 2021
Long-term persistence of rituximab in patients with rheumatoid arthritis: an evaluation of the UCL cohort from 1998 to 2020Caitlin Norris-Grey, Geraldine Cambridge, Samantha Moore, et al.
Frontiers in Medicine|June 17, 2021
Similarities and Differences Between Juvenile and Adult SpondyloarthropathiesCorinne Fisher, Coziana Ciurtin, Maria Leandro, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Hospital Medicine (London, England : 2005)|October 8, 2014
Abnormal antibodies: what do you do?Maria Mouyis, Maria Leandro
British Journal of Haematology|May 27, 2009
Rituximab in non-haematological disorders of adults and its mode of actionVickie McDonald, Maria Leandro
Lupus|January 18, 2021
Rituximab - The first twenty yearsMaria Leandro, David A Isenberg
Arthritis Research & Therapy|June 8, 2004
B cell depletion in autoimmune diseaseClaire Gorman, Maria Leandro, David Isenberg
Dermatologic Therapy|August 7, 2013
Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumabThivi Maruthappu, Maria Leandro, Susie D Morris
Biologicals : Journal of the International Association of Biological Standardization|December 8, 2020
Anti-CD20 monoclonal antibodies in Systemic Lupus ErythematosusKavina Shah, Mark Cragg, Maria Leandro, et al.
BMC Rheumatology|September 6, 2019
Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysisAshleigh Hennessey, Joanna Lukawska, Geraldine Cambridge, et al.
Drug Discovery Today|June 26, 2016
Optimising B-cell depletion in autoimmune disease: is obinutuzumab the answer?Venkat Reddy, Lekh N Dahal, Mark S Cragg, et al.
Rheumatology (Oxford, England)|March 26, 2021
Long-term persistence of rituximab in patients with rheumatoid arthritis: an evaluation of the UCL cohort from 1998 to 2020Caitlin Norris-Grey, Geraldine Cambridge, Samantha Moore, et al.
Frontiers in Medicine|June 17, 2021
Similarities and Differences Between Juvenile and Adult SpondyloarthropathiesCorinne Fisher, Coziana Ciurtin, Maria Leandro, et al.
Pageof 4